mefloquine has been researched along with metoprolol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcorn, J; Auschwitz, JM; Das, U; Dimmock, JR; Hickman, MR; Leed, SE; Singh, RS | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baune, B; Farinotti, R; Furlan, V; Taburet, AM | 1 |
1 review(s) available for mefloquine and metoprolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for mefloquine and metoprolol
| Article | Year |
|---|---|
From a cytotoxic agent to the discovery of a novel antimalarial agent.
Topics: Antimalarials; Caco-2 Cells; Drug Discovery; Drug Resistance; Humans; Inhibitory Concentration 50; Morpholines; Piperidones; Plasmodium falciparum | 2013 |
In vitro effects of racemates, separate enantiomers and major metabolites of mefloquine and halofantrine on metoprolol biotransformation by rat liver microsomes.
Topics: Animals; Antimalarials; Biotransformation; Male; Mefloquine; Metoprolol; Microsomes, Liver; Phenanthrenes; Rats; Rats, Sprague-Dawley; Stereoisomerism | 1999 |